|
|
Adapthealth Corp (NASDAQ: AHCO) |
|
|
|
| |
AHCO's Revenue Growth by Quarter and Year
Adapthealth 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| AHCO Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
858.23
|
780.28
|
702.11
|
| III Quarter |
September |
805.86
|
804.03
|
756.50
|
653.29
|
| II Quarter |
June |
805.98
|
793.29
|
727.61
|
617.02
|
| I Quarter |
March |
792.50
|
744.63
|
706.20
|
482.12
|
| FY |
|
2,404.34
|
3,200.18
|
2,970.59
|
2,454.54
|
| AHCO Revenue third quarter 2024 Y/Y Growth Comment |
Adapthealth Corp reported Revenue growth of 0.23% year on year in the third quarter 2024, to $ 805.86 millions, this is lower than Adapthealth Corp 's recent average Revenue improvement of 33.97%.
Looking into third quarter 2024 results within Healthcare Facilities industry 28 other companies have achieved higher Revenue growth. While Adapthealth Corp ' s Revenue increase of 0.23% ranks overall at the positon no. 1662 in the third quarter 2024.
|
| AHCO Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
9.99 % |
11.13 % |
101.51 % |
| III Quarter |
September |
0.23 % |
6.28 % |
15.8 % |
129.7 % |
| II Quarter |
June |
1.6 % |
9.03 % |
17.92 % |
165.82 % |
| I Quarter |
March |
6.43 % |
5.44 % |
46.48 % |
151.84 % |
| FY |
|
- |
7.73 % |
21.02 % |
132.35 % |
AHCO Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
6.74 % |
3.14 % |
7.47 % |
| III Quarter |
September |
-0.02 % |
1.35 % |
3.97 % |
5.88 % |
| II Quarter |
June |
1.7 % |
6.53 % |
3.03 % |
27.98 % |
| I Quarter |
March |
-7.66 % |
-4.57 % |
0.58 % |
38.37 % |
| FY (Year on Year) |
|
- |
7.73 % |
21.02 % |
132.35 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 132.35 % |
33.97 % |
4.49 % |
| (Dec 31 2021) |
|
(Sep 30 2024) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 132.35 % |
33.97 % |
4.49 % |
| (Dec 31 2021) |
|
(Sep 30 2024) |
|
| Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Adapthealth 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 38.37 % |
8.93 % |
-7.66 % |
| (Mar 31 2021) |
|
|
| AHCO's III. Quarter Q/Q Revenue Comment |
In the III. Quarter 2024 Adapthealth Corp disclosed decrease in Revenue from the second quarter by -0.02% to $ 805.86 millions, from $ 805.98 millions achived in the previous reporting period.
Even seasonal influence which commonly energize III. Quarter 2024 Revenue, this simply could not be enough to recover Healthcare Facilities's company III. Quarter achievement, Most analysts wrote and mentioned that average sequential Revenue growth is at 8.93% for AHCO.
Within Healthcare Facilities industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Adapthealth 's Revenue growth quarter on quarter, overall rank is 2032. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 38.37 % |
8.93 % |
-7.66 % |
| (Mar 31 2021) |
|
|
| AHCO's III. Quarter Q/Q Revenue Comment |
In the III. Quarter 2024 Adapthealth Corp reported decrease in Revenue from the previous quarter by -0.02% to $ 805.86 millions, from $ 805.98 millions achived in the previous reporting period.
Albeit periodic factors which commonly elevate III. Quarter 2024 performance, this simply was not sufficient to salvage AHCO's performance, Most analysts wrote.
Within Healthcare Facilities industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Adapthealth 's Revenue growth quarter on quarter, overall rank is 2032. |
|
Adapthealth 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
| Cumulative Revenue 12 Months Ending |
$ 3,262.56 |
$ 3,260.74 |
$ 3,248.05 |
$ 3,200.18 |
$ 3,122.23 |
| Y / Y Revenue Growth (TTM) |
4.49 % |
6.05 % |
7.94 % |
7.73 % |
7.95 % |
| Year on Year Revenue Growth Overall
Ranking |
# 1107 |
# 639 |
# 369 |
# 331 |
# 238 |
| Seqeuential Revenue Change (TTM) |
0.06 % |
0.39 % |
1.5 % |
2.5 % |
1.55 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1662 |
# 1111 |
# 1552 |
# 1094 |
# 1208 |
| Cumulative Revenue growth
Comment |
With the quarterly Revenue reported in the Sep 30 2024 period, Adapthealth 's cumulative twelve months Revenue were $ 3,263 millions, company would post below average annual Revenue growth of 1.55% year on year, if the fiscal year would end at Sep 30 2024.
A slow-down in the Adapthealth 's Revenue growth from the 805.98% growth in Jun 30 2024.
In the Healthcare sector 223 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 639 to 1107. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
132.35 % |
33.97 % |
4.49 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
132.35 % |
33.97 % |
4.49 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 29 |
| Sector |
# 283 |
| S&P 500 |
# 1662 |
|
| Cumulative Revenue growth
Comment |
With the quarterly Revenue reported in the Sep 30 2024 period, Adapthealth 's cumulative twelve months Revenue were $ 3,263 millions, company would post below average annual Revenue growth of 4.49% year on year, if the fiscal year would end at Sep 30 2024.
A slow-down in the Adapthealth 's Revenue growth from the 805.98% growth in Jun 30 2024.
In the Healthcare sector 223 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 639 to 1107. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
132.35 % |
33.97 % |
4.49 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
132.35 % |
33.97 % |
4.49 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 29 |
| Sector |
# 283 |
| S&P 500 |
# 1662 |
|
0.38%